• العربية
    • Biotricity, News

    Biotricity signs Distribution Agreement to expand access for its Cardiac Monitoring Solutions

    November 16, 2022

    Biotricity Inc. (Biotricity) has signed a distribution agreement with one of the Top 10 US medical device distributors to distribute its cardiac monitoring solutions, Bioflux and Biotres.  With the commercialization of its Bioflux and Biotres products, Biotricity has increased its total addressable market from $1 billion to approximately $6 billion.

    Recent Posts

    Recent Comments

    No comments to show.
    Recent Posts
    Archives
    Categories
    Meta
    Previous
    Biotricity surpasses $10 million in annual revenue run rate
    Next
    Biotricity reports financial results for Fiscal 2023 Second Quarter
    Privacy Settings
    We use cookies to enhance your experience while using our website. If you are using our Services via a browser you can restrict, block or remove cookies through your web browser settings. We also use content and scripts from third parties that may use tracking technologies. You can selectively provide your consent below to allow such third party embeds. For complete information about the cookies we use, data we collect and how we process them, please check our Privacy Policy
    Youtube
    Consent to display content from - Youtube
    Vimeo
    Consent to display content from - Vimeo
    Google Maps
    Consent to display content from - Google
    Spotify
    Consent to display content from - Spotify
    Sound Cloud
    Consent to display content from - Sound
    Save